Notice of Change in Key Dates for RFA-AI-20-078, “Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)”
Notice Number:
NOT-AI-21-049

Key Dates

Release Date:

April 28, 2021

Related Announcements

RFA-AI-20-078 - Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Environmental Health Sciences (NIEHS)

Purpose

This Notice is to alert potential applicants of a change to the Key Dates for RFA-AI-20-078, Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed).

The following changes (noted in italics) have been made:


Currently reads:

Part 1. Overview Information

Key Dates


Posted Date

January 12, 2021


Open Date (Earliest Submission Date)

May 04, 2021


Letter of Intent Due Date(s)

30 days before application due date


Application Due Date(s)

June 4, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


AIDS Application Due Date(s)

June 4, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


Scientific Merit Review

October 2021


Advisory Council Review

January 2022


Earliest Start Date

March 2022


Expiration Date

June 05, 2021


Due Dates for E.O. 12372

Not Applicable


Revised to read:

Part 1. Overview Information

Key Dates


Posted Date

January 12, 2021


Open Date (Earliest Submission Date)

May 18, 2021


Letter of Intent Due Date(s)

30 days before application due date


Application Due Date(s)

June 18, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


AIDS Application Due Date(s)

June 18, 2021

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


Scientific Merit Review

October 2021


Advisory Council Review

January 2022


Earliest Start Date

March 2022


Expiration Date

June 19, 2021


Due Dates for E.O. 12372

Not Applicable


All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Mercy Prabhudas, Ph.D., M.B.A.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3534
Email: mprabhudas@niaid.nih.gov

Que Dang, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-6181
Email: que.dang@nih.gov

Anjali Singh, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3030
Email: anjalisingh@niaid.nih.gov

Michael C. Humble, Ph.D.
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3272
Email: humble@niehs.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices